Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes

American Heart Journal

Volumn 149, Issue 2, 2005, Pages 268-274

  Bodí, Vicent ^a   Sanchis, Juan ^a   Llàcer, Àngel ^a   Fácila, Lorenzo ^a   Núñez, Julio ^a   Pellicer, Mauricio ^a   Bertomeu, Vicente ^a   Ruiz, Vicente ^a   Chorro, Francisco J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; HOMOCYSTEINE; MYOGLOBIN; TROPONIN I;

AGED; ARTICLE; CONTROLLED STUDY; CORONARY RISK; DISEASE MARKER; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT ELEVATION;

EID: 14844309692     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.05.053     Document Type: Article

References (34)

1. P.A. Heidenreich, T. Alloggiamento, and K. Melsop The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis J. Am. Coll. Cardiol. 38 2001 478 485
2. C.W. Hamm Cardiac biomarkers for rapid evaluation of chest pain Circulation 104 2001 1454 1456
3. B.U. Goldman, R.H. Christenson, and C.W. Hamm Implications of troponin testing in clinical medicine Curr. Control. Trials, Cardiovasc. Med. 2 2001 75 84
4. J.A. De Lemos, D.A. Morrow, and C.M. Gibson The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes: results from the TIMI 11B and TACTICS-TIMI 18 studies J. Am. Coll. Cardiol. 40 2002 238 244
5. J. Sanchis, V. Bodí, and A. Llácer Usefulness of concomitant myoglobin and troponin elevation as biochemical marker of mortality in non-ST-segment elevation acute coronary syndromes Am. J. Cardiol. 91 2003 13 16
6. E.R. Ferreirós, C.P. Boissonnet, and R. Pizarro Independent prognostic value of elevated C-reactive protein in unstable angina Circulation 100 1999 1958 1963
7. D.J. Rader Inflammatory markers of coronary risk N. Engl. J. Med. 343 2000 1179 1182
8. B. Lindahl, H. Toss, and A. Siegbahn Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease N. Engl. J. Med. 343 2000 1139 1147
9. H. Toss, B. Lindahl, and A. Siegbahn Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable artery disease Circulation 96 1997 4204 4210
10. C. Mueller, H.J. Buettner, and J.M. Hodgson Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients Circulation 105 2002 1412 1415
11. R.J. De Winter, J. Fischer, and R. Bholasingh C-reactive protein and cardiac troponin T in risk stratification: differences in optimal timing of tests early after the onset of chest pain Clin. Chem. 46 2000 1597 1603
12. V. Bodí, L. Fácila, and J. Sanchis Short-term prognosis of patients admitted for probable acute coronary syndrome without ST-segment elevation. Role of new myocardial damage markers and acute-phase reactants Rev. Esp. Cardiol. 55 2002 823 830
13. J. Oldgren, L. Wallentin, and L. Grip Myocardial damage, inflammation and thrombin inhibition in unstable coronary artery disease Eur. Heart J. 24 2003 86 93
14. E. Bozkurt, M.K. Erol, and S. Keles Relation of plasma homocysteine levels to intracoronary thrombus in unstable angina pectoris and in non-Q wave acute myocardial infarction Am. J. Cardiol. 90 2002 413 415
15. P. Bogaty, P. Poirier, and S. Simard Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina Circulation 103 2001 3062 3068
16. G. Schnyder, Y. Flammer, and M. Roffi Plasma homocysteine levels and late outcome after coronary angioplasty J. Am. Coll. Cardiol. 40 2002 1769 1776
17. M.N. Zairis, J.A. Ambrose, and S.J. Manousakis The impact of plasma levels of C-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting J. Am. Coll. Cardiol. 40 2002 1375 1382
18. M. Al-Obaidi, P.J. Stubbs, and P. Collinson Elevated homocysteine levels are associated with increased ischemic myocardial injury in acute coronary syndromes J. Am. Coll. Cardiol. 36 2000 1217 1222
19. Joint European Society of Cardiology American College of Cardiology Committee Myocardial infarction redefined. A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction Eur. Heart J. 21 2000 1502 1513
20. L.K. Newby, M.V. Bhapkar, and H.D. White Predictors of 90-day outcome in patients stabilized after acute coronary syndromes Eur. Heart J. 24 2003 172 182
21. V. Mathew, and D.R. Holmes Outcomes in diabetics undergoing revascularization. The long and the short of it J. Am. Coll. Cardiol. 40 2002 424 427
22. P. Kaul, Y. Fu, and W.Ch. Chang Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb J. Am. Coll. Cardiol. 38 2001 64 71
23. P. Kaul, K. Newby, and Y. Fu Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients J. Am. Coll. Cardiol. 41 2003 371 380
24. L.K. Newby, A.B. Storrow, and W.B. Gibler Bedside multimarker testing for risk stratification in chest pain units: the Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin and Troponin I (CHECKMATE) study Circulation 103 2001 1832 1837
25. B. Lindahl, E. Diderholm, and B. Lagerqvist Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy J. Am. Coll. Cardiol. 38 2001 979 986
26. B. Jurlander, E.R. Farhi, and J.J. Banas Coronary angiographic findings and troponin T in patients with unstable angina pectoris Am. J. Cardiol. 85 2000 810 814
27. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
28. E.T. Yeh, and J.T. Willerson Coming of age of C-reactive protein. Using inflammation markers in cardiology Circulation 107 2003 370 372
29. J.F. Keaney, and J.A. Vita The value of inflammation for predicting unstable angina N. Engl. J. Med. 347 2002 55 57
30. M.R. Cusack, M.S. Marber, and P.D. Lambiase Systemic inflammation in unstable angina is the result of myocardial necrosis J. Am. Coll. Cardiol. 39 2002 1917 1923
31. V. Bodí, J. Núñez, and J. Sanchis Why does C-reactive protein increase in non-ST elevation acute coronary syndromes? Role of myocardial damage Int. J. Cardiol. 92 2003 129 135
32. E. Sehnal, and J. Slany Fibrinogen-The key to familial CHD or just another shadow in Plato's allegory? Eur. Heart J. 23 2002 1231 1233
33. J.P. Ottervanger, P. Armstrong, and E.S. Barnathan Long-term results after the glycoprotein IIb/IIIa inhibitor abciximab in unstable angina Circulation 107 2003 437 442
34. M.S. Sabatine, D.A. Morrow, and J.A. de Lemos Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Simultaneous assessment of troponin I, C-reactive protein and B-type natriuretic peptide Circulation 105 2002 1760 1763